Guillaume Schurtz

ORCID: 0000-0001-6679-2379
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mechanical Circulatory Support Devices
  • Cardiac Arrest and Resuscitation
  • Cardiac Structural Anomalies and Repair
  • Heart Failure Treatment and Management
  • Cardiac Valve Diseases and Treatments
  • Acute Myocardial Infarction Research
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiovascular Function and Risk Factors
  • Infective Endocarditis Diagnosis and Management
  • Coronary Interventions and Diagnostics
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Arrhythmias and Treatments
  • Sepsis Diagnosis and Treatment
  • Cardiac electrophysiology and arrhythmias
  • Cardiac Imaging and Diagnostics
  • Ultrasound in Clinical Applications
  • COVID-19 and healthcare impacts
  • Cardiac pacing and defibrillation studies
  • Heme Oxygenase-1 and Carbon Monoxide
  • Opioid Use Disorder Treatment
  • Aortic Disease and Treatment Approaches
  • Pulmonary Hypertension Research and Treatments
  • COVID-19 Clinical Research Studies
  • Venous Thromboembolism Diagnosis and Management
  • Cardiovascular Issues in Pregnancy

Lille’s Cardiology Hospital
2014-2025

Université de Lille
2013-2025

Centre Hospitalier Universitaire de Lille
2015-2024

Institut Pasteur de Lille
2015-2024

Inserm
2015-2024

Groupe Hospitalier de l'Institut Catholique de Lille
2021-2024

Alliance nationale pour les sciences de la vie et de la santé
2022

Valve (United States)
2021

Background: No randomized study powered to compare balloon expandable (BE) with self expanding (SE) transcatheter heart valves (THVs) on individual end points after aortic valve replacement has been conducted date. Methods: From January 2013 December 2015, the FRANCE-TAVI nationwide registry (Registry of Aortic Valve Bioprostheses Established by Catheter) included 12 141 patients undergoing BE-THV (Edwards, n=8038) or SE-THV (Medtronic, n=4103) for treatment native stenosis. Long term...

10.1161/circulationaha.119.043785 article EN Circulation 2019-11-16

Postprocedural aortic regurgitation occurs in 10 to 20% of patients undergoing transcatheter aortic-valve replacement (TAVR) for stenosis. We hypothesized that assessment defects high-molecular-weight (HMW) multimers von Willebrand factor or point-of-care hemostasis could be used monitor during TAVR.We enrolled 183 TAVR. Patients with after the initial implantation, as identified by means transesophageal echocardiography, underwent additional balloon dilation correct regurgitation. HMW and...

10.1056/nejmoa1505643 article EN New England Journal of Medicine 2016-07-27

Rationale: Percutaneous aortic valve procedures are a major breakthrough in the management of patients with stenosis. Residual gradient and residual regurgitation predictors midterm long-term outcome after percutaneous procedures. We hypothesized that (1) induction/recovery high molecular weight (HMW) multimers von Willebrand factor defect could be instantaneous acute changes blood flow, (2) bedside point-of-care assay (platelet function analyzer-closure time adenine DI-phosphate...

10.1161/circresaha.116.305046 article EN Circulation Research 2015-02-11

Abstract Aims Published data on cardiogenic shock (CS) are scarce and mostly focused small registries of selected populations. The aim this study was to examine the current CS picture define independent correlates 30 day mortality in a large non‐selected cohort. Methods results FRENSHOCK is prospective multicentre observational survey conducted metropolitan French intensive care units cardiac between April October 2016. There were 772 patients enrolled (mean age 65.7 ± 14.9 years; 71.5%...

10.1002/ehf2.13734 article EN ESC Heart Failure 2021-12-31

While recreational drug use is a risk factor for cardiovascular events, its exact prevalence and prognostic impact in patients admitted these events are not established. We aimed to assess the of association with in-hospital major adverse (MAEs) intensive cardiac care units (ICCU).In Addiction Intensive Cardiac Care Units (ADDICT-ICCU) study, systematic screening drugs was performed by prospective urinary testing all ICCU 39 French centres from 7 22 April 2021. The primary outcome detection....

10.1136/heartjnl-2023-322520 article EN Heart 2023-08-15

The aim of the study was to assess outcomes balloon aortic valvuloplasty (BAV) as a rescue therapy in patients with cardiogenic shock (CS) related severe stenosis (AS).Forty-four consecutive patients, n=31 hypotensive CS (HCS) and n=13 non-hypotensive (NHCS) due acutely decompensated AS, from two centres were treated urgent BAV. composite primary endpoint mortality or recurrent at one-year follow-up. These (77.3±8.1 years old; 75% male) had mean EuroSCORE II 41.6±13.7%. One-month 47%. Twelve...

10.4244/eij-d-18-00029 article EN EuroIntervention 2018-08-01

Background Ultrasound ( US ) guidance provides the unique opportunity to control puncture zone of artery during transfemoral transcatheter aortic valve replacement and may decrease major vascular complications VC life‐threatening or bleeding complications. This study aimed evaluate clinical impact using a propensity score–matched comparison. Methods Results was implemented as default approach for all cases in our institution June 2013. We defined 3 groups consecutive patients according...

10.1161/jaha.119.014916 article EN cc-by-nc-nd Journal of the American Heart Association 2020-03-16

Chronic kidney disease (CKD) is one of the leading causes death worldwide, closely interrelated with cardiovascular diseases, ultimately to failure both organs - so-called "cardiorenal syndrome". Despite this burden, data related cardiogenic shock outcomes in CKD patients are scarce.

10.1016/j.acvd.2024.01.006 article EN cc-by Archives of cardiovascular diseases 2024-03-20

Although predominant in routine practice, non-ischaemic cardiogenic shock (NICS) remains underrepresented past studies, mainly focused on ischaemic (CS). This study aims to describe the current NICS picture and define its independent correlates of short- long-term outcomes. FRENSHOCK is a prospective registry including 772 CS patients from 49 centers. One-year mortality was primary outcome. One-month composite 1-year mortality, heart transplantation (HTx), or ventricular assistance device...

10.1002/ehf2.15046 article EN cc-by-nc-nd ESC Heart Failure 2025-03-25

For assessing predictors of early mortality following hospitalization for electrical storm (ES), only limited data are available. The purpose this study was to assess the incidence and in intensive care unit (ICU) ES a large retrospective study.In study, we included all patients who were hospitalized from July 2015 May 2020 our tertiary centre. A total 253 included. median age 66 [56; 73], 64% had ischemic cardiomyopathy. 37% presented hemodynamic instability requiring catecholamine at...

10.1093/ehjacc/zuac044 article EN European Heart Journal Acute Cardiovascular Care 2022-04-14

Abstract Aims Impact of skin mottling has been poorly studied in patients admitted for cardiogenic shock. This study aimed to address this issue and identify determinants 30-day 1-year mortality a large shock cohort all etiologies. Methods results FRENSHOCK is prospective multicenter observational registry conducted French critical care units between April October, 2016. Among the 772 enrolled (mean age 65.7 ± 14.9 years; 71.5% male), 660 had assessed at admission (85.5%) with almost 39%...

10.1186/s13613-023-01175-0 article EN cc-by Annals of Intensive Care 2023-09-06
Coming Soon ...